Found: 23
Select item for more details and to access through your institution.
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 259, doi. 10.1002/cpdd.237
- By:
- Publication type:
- Article
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1646-4
- By:
- Publication type:
- Article
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 12, p. 1832, doi. 10.1359/JBMR.070809
- By:
- Publication type:
- Article
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 4, p. 1045, doi. 10.1007/s10067-021-05908-z
- By:
- Publication type:
- Article
Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 9, p. 2501, doi. 10.1007/s10067-019-04543-z
- By:
- Publication type:
- Article
Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Underuse of Methotrexate in the Treatment of Rheumatoid Arthritis: A National Analysis of Prescribing Practices in the US.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature review.
- Published in:
- Arthritis Care & Research, 2011, v. 63, n. 5, p. 660, doi. 10.1002/acr.20413
- By:
- Publication type:
- Article
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 4, p. 1, doi. 10.1186/ar3430
- By:
- Publication type:
- Article
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial.
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 256, doi. 10.1093/rheumatology/keaa234
- By:
- Publication type:
- Article
Use of Precision Medicine to Guide Treatment of Patients With Rheumatoid Arthritis: Comment on the Article by Tao et al.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
The Science Behind Biosimilars.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 3, p. 334, doi. 10.1002/art.40388
- By:
- Publication type:
- Article
Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 2, p. 204, doi. 10.1002/art.40364
- By:
- Publication type:
- Article
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 5, p. 1255, doi. 10.1007/s40744-023-00576-8
- By:
- Publication type:
- Article
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 2, p. 357, doi. 10.1007/s40744-022-00507-z
- By:
- Publication type:
- Article
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 1, p. 226, doi. 10.1007/s12325-020-01501-z
- By:
- Publication type:
- Article
Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or Continuing Biosimilar Therapy: Week 54–78 Data From a Randomized, Double-Blind, Phase III Trial
- Published in:
- BioDrugs, 2020, v. 34, n. 2, p. 197, doi. 10.1007/s40259-019-00403-z
- By:
- Publication type:
- Article
Biosimilars for Rheumatoid Arthritis: Riding the 2023 Wave [Podcast].
- Published in:
- Open Access Rheumatology: Research & Reviews, 2023, v. 15, p. 207, doi. 10.2147/OARRR.S443235
- By:
- Publication type:
- Article
Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate.
- Published in:
- Open Access Rheumatology: Research & Reviews, 2018, v. 10, p. 97, doi. 10.2147/OARRR.S169152
- By:
- Publication type:
- Article
Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial.
- Published in:
- Journal of the American Geriatrics Society, 2004, v. 52, n. 5, p. 666, doi. 10.1111/j.1532-5415.2004.52201.x
- By:
- Publication type:
- Article